• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Fibrinolytic niche is required for alveolar type 2 cell-mediated alveologenesis via a uPA-A6-CD44-ENaC signal cascade.

作者信息

Ali Gibran, Zhang Mo, Zhao Runzhen, Jain Krishan G, Chang Jianjun, Komatsu Satoshi, Zhou Beiyun, Liang Jiurong, Matthay Michael A, Ji Hong-Long

机构信息

Department of Cellular and Molecular Biology, University of Texas Health Science Center at Tyler, Tyler, TX, USA.

Institute of Lung and Molecular Therapy, Xinxiang Medical University, Xinxiang, Henan, China.

出版信息

Signal Transduct Target Ther. 2021 Feb 27;6(1):97. doi: 10.1038/s41392-021-00511-9.

DOI:10.1038/s41392-021-00511-9
PMID:33640905
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7910758/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/51e1/7914251/aa901fbd8023/41392_2021_511_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/51e1/7914251/aa901fbd8023/41392_2021_511_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/51e1/7914251/aa901fbd8023/41392_2021_511_Fig1_HTML.jpg

相似文献

1
Fibrinolytic niche is required for alveolar type 2 cell-mediated alveologenesis via a uPA-A6-CD44-ENaC signal cascade.通过尿激酶型纤溶酶原激活剂-A6-细胞表面抗原CD44-上皮钠通道信号级联反应，2型肺泡细胞介导的肺泡形成需要纤维蛋白溶解微环境。
Signal Transduct Target Ther. 2021 Feb 27;6(1):97. doi: 10.1038/s41392-021-00511-9.
2
Urokinase-type plasminogen activator (uPA) is not essential for epithelial sodium channel (ENaC)-mediated sodium retention in experimental nephrotic syndrome.尿激酶型纤溶酶原激活物 (uPA) 对于实验性肾病综合征中上皮钠通道 (ENaC) 介导的钠潴留并非必需。
Acta Physiol (Oxf). 2019 Dec;227(4):e13286. doi: 10.1111/apha.13286. Epub 2019 May 20.
3
Regulation of epithelial sodium channels in urokinase plasminogen activator deficiency.尿激酶型纤溶酶原激活物缺乏时上皮钠通道的调节
Am J Physiol Lung Cell Mol Physiol. 2014 Oct 15;307(8):L609-17. doi: 10.1152/ajplung.00126.2014. Epub 2014 Aug 29.
4
Proteolytic regulation of epithelial sodium channels by urokinase plasminogen activator: cutting edge and cleavage sites.尿激酶型纤溶酶原激活剂对上皮钠通道的蛋白水解调节：前沿进展与切割位点
J Biol Chem. 2015 Feb 27;290(9):5241-55. doi: 10.1074/jbc.M114.623496. Epub 2015 Jan 2.
5
Enhancement of alveolar epithelial sodium channel activity with decreased cystic fibrosis transmembrane conductance regulator expression in mouse lung.降低囊性纤维化跨膜电导调节因子表达增强小鼠肺肺泡上皮钠通道活性。
Am J Physiol Lung Cell Mol Physiol. 2011 Oct;301(4):L557-67. doi: 10.1152/ajplung.00094.2011. Epub 2011 Jul 8.
6
TM4SF5-mediated CD44v8-10 splicing variant promotes survival of type II alveolar epithelial cells during idiopathic pulmonary fibrosis.TM4SF5 介导的 CD44v8-10 剪接变体促进特发性肺纤维化中 II 型肺泡上皮细胞的存活。
Cell Death Dis. 2019 Sep 9;10(9):645. doi: 10.1038/s41419-019-1878-5.
7
Regulation of p53-mediated changes in the uPA-fibrinolytic system and in lung injury by loss of surfactant protein C expression in alveolar epithelial cells.肺泡上皮细胞表面活性蛋白C表达缺失对p53介导的尿激酶型纤溶酶原激活物-纤维蛋白溶解系统变化及肺损伤的调控作用
Am J Physiol Lung Cell Mol Physiol. 2017 Jun 1;312(6):L783-L796. doi: 10.1152/ajplung.00291.2016. Epub 2017 Apr 6.
8
CD44 enhances invasion of basal-like breast cancer cells by upregulating serine protease and collagen-degrading enzymatic expression and activity.CD44 通过上调丝氨酸蛋白酶和胶原降解酶的表达和活性增强基底样乳腺癌细胞的侵袭。
Breast Cancer Res. 2012 May 23;14(3):R84. doi: 10.1186/bcr3199.
9
Regulation of lung injury and fibrosis by p53-mediated changes in urokinase and plasminogen activator inhibitor-1.p53 介导的尿激酶和纤溶酶原激活物抑制剂-1 变化对肺损伤和纤维化的调节。
Am J Pathol. 2013 Jul;183(1):131-43. doi: 10.1016/j.ajpath.2013.03.022. Epub 2013 May 8.
10
Plasminogen activator inhibitor-1 suppresses profibrotic responses in fibroblasts from fibrotic lungs.纤溶酶原激活物抑制剂-1抑制纤维化肺成纤维细胞中的促纤维化反应。
J Biol Chem. 2015 Apr 10;290(15):9428-41. doi: 10.1074/jbc.M114.601815. Epub 2015 Feb 3.

引用本文的文献

1
Surfactant Protein-C Regulates Alveolar Type 2 Epithelial Cell Lineages via the CD74 Receptor.表面活性蛋白C通过CD74受体调节肺泡II型上皮细胞谱系。
J Respir Biol Transl Med. 2024 Dec;1(4). doi: 10.70322/jrbtm.2024.10017. Epub 2024 Oct 11.
2
MOCHA's advanced statistical modeling of scATAC-seq data enables functional genomic inference in large human cohorts.MOCHA 对 scATAC-seq 数据的高级统计建模可实现大规模人类队列的功能基因组推断。
Nat Commun. 2024 Aug 9;15(1):6828. doi: 10.1038/s41467-024-50612-6.
3
Realveolarization with inhalable mucus-penetrating lipid nanoparticles for the treatment of pulmonary fibrosis in mice.

本文引用的文献

1
Plasmin improves blood-gas barrier function in oedematous lungs by cleaving epithelial sodium channels.纤溶酶通过裂解上皮钠通道改善水肿肺的血气屏障功能。
Br J Pharmacol. 2020 Jul;177(13):3091-3106. doi: 10.1111/bph.15038. Epub 2020 May 11.
2
Proliferative regulation of alveolar epithelial type 2 progenitor cells by human gene.人基因对肺泡上皮 2 型祖细胞的增殖调控。
Theranostics. 2019 Oct 18;9(26):8155-8170. doi: 10.7150/thno.37023. eCollection 2019.
3
Urokinase-type plasminogen activator (uPA) is not essential for epithelial sodium channel (ENaC)-mediated sodium retention in experimental nephrotic syndrome.
可吸入黏液穿透脂质纳米粒复张术治疗小鼠肺纤维化。
Sci Adv. 2024 Jun 14;10(24):eado4791. doi: 10.1126/sciadv.ado4791. Epub 2024 Jun 12.
4
Alveolar Type 2 Epithelial Cell Organoids: Focus on Culture Methods.肺泡II型上皮细胞类器官：聚焦培养方法
Biomedicines. 2023 Nov 12;11(11):3034. doi: 10.3390/biomedicines11113034.
5
Repairing Mechanisms for Distal Airway Injuries and Related Targeted Therapeutics for Chronic Lung Diseases.远端气道损伤的修复机制及慢性肺部疾病的相关靶向治疗。
Cell Transplant. 2023 Jan-Dec;32:9636897231196489. doi: 10.1177/09636897231196489.
6
PAI-1 regulates AT2-mediated re-alveolarization and ion permeability.PAI-1 调节 AT2 介导的再肺泡化和离子通透性。
Stem Cell Res Ther. 2023 Jul 27;14(1):185. doi: 10.1186/s13287-023-03414-4.
7
Fibrinolytic system and COVID-19: From an innovative view of epithelial ion transport.纤维蛋白溶解系统与 COVID-19：从上皮细胞离子转运的创新视角看。
Biomed Pharmacother. 2023 Jul;163:114863. doi: 10.1016/j.biopha.2023.114863. Epub 2023 May 9.
8
PAI-1 regulates AT2-mediated re-alveolarization and ion permeability.纤溶酶原激活物抑制剂-1调节血管紧张素Ⅱ1型受体介导的再肺泡化和离子通透性。
Res Sq. 2023 Mar 1:rs.3.rs-2289657. doi: 10.21203/rs.3.rs-2289657/v1.
9
Wnt5a/β-catenin axis is involved in the downregulation of AT2 lineage by PAI-1.Wnt5a/β-catenin 轴参与了 PAI-1 对 AT2 谱系的下调。
Am J Physiol Lung Cell Mol Physiol. 2022 Nov 1;323(5):L515-L524. doi: 10.1152/ajplung.00202.2022. Epub 2022 Sep 13.
10
Functional characterization of ion channels expressed in kidney organoids derived from human induced pluripotent stem cells.人诱导多能干细胞衍生的肾类器官中表达的离子通道的功能特征。
Am J Physiol Renal Physiol. 2022 Oct 1;323(4):F479-F491. doi: 10.1152/ajprenal.00365.2021. Epub 2022 Aug 18.
尿激酶型纤溶酶原激活物 (uPA) 对于实验性肾病综合征中上皮钠通道 (ENaC) 介导的钠潴留并非必需。
Acta Physiol (Oxf). 2019 Dec;227(4):e13286. doi: 10.1111/apha.13286. Epub 2019 May 20.
4
Proteolytic regulation of epithelial sodium channels by urokinase plasminogen activator: cutting edge and cleavage sites.尿激酶型纤溶酶原激活剂对上皮钠通道的蛋白水解调节：前沿进展与切割位点
J Biol Chem. 2015 Feb 27;290(9):5241-55. doi: 10.1074/jbc.M114.623496. Epub 2015 Jan 2.
5
Regulation of lung injury and repair by Toll-like receptors and hyaluronan.Toll样受体与透明质酸对肺损伤及修复的调控
Nat Med. 2005 Nov;11(11):1173-9. doi: 10.1038/nm1315. Epub 2005 Oct 23.